Jeremy M. Levin, CEO at Ovid Therapeutics Inc. (OVID), bought 60,000 shares at $2.50 ($150K) on 2019-10-08, disclosed to the SEC on 2019-10-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| OVID | BUY | 2019-02-26 | $150K | — | Filing → |
| OVID | BUY | 2017-08-28 | $219K | — | Filing → |